Cronos Group Inc CRON
TSX · Canada · Health Technology
CAD 4.57-0.13 (-2.77%)
Market closed· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Investing.com -- Cronos Group’s manufacturing capacity, cannabis genetics and branded product portfolio are drawing renewed attention after the company showcased its operations at an investor day, prompting an analyst to raise its 12-month price target to C$5.50 from C$5.25.
Global markets are adjusting to higher long term interest rates, with bond yields in countries like Australia moving toward levels not seen in years. That shift keeps investors focused on balance sheets and cash flow rather than hype. For Canadian penny stocks, it creates a window to look at lower priced businesses that still keep their finances in order. This article breaks down three such opportunities from our financially focused screener. The three penny stocks covered below are only a...
Cronos Group (NASDAQ:CRON) used its first Investor Day to outline its cultivation, genetics, brand and financial strategy, emphasizing its purpose-built greenhouse partnership with Mucci Farms, continued international expansion and a focus on cash flow generation. Chief Executive Officer Mike Goren
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.
